Springer

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Morris
    Morris
  4. Solit
    Solit
  5. Bajorin
    Bajorin
  6. Slovin
    Slovin
  7. Feldman
    Feldman
  8. Bosl
    Bosl
  9. Rathkopf
    Rathkopf
  10. Russo
    Russo

Groups

  1. Department of Medicine (145)
  2. Genitourinary Oncology Service (145)
  3. Solid Tumor Oncology Division (145)
  4. Radiology, Department of (39)
  5. GSK Faculty (36)
  6. Surgery (25)
  7. Survivorship Research (23)
  8. Body Imaging Service (22)
  9. Department of Pathology and Laboratory Medicine (21)
  10. Epidemiology and Biostatistics (20)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (111)
  2. Meeting Abstract (18)
  3. Book Section (12)
  4. Review (3)
  5. Guidelines (1)
Groups
  1. Department of Medicine (145)
  2. Genitourinary Oncology Service (145)
  3. Solid Tumor Oncology Division (145)
  4. Radiology, Department of (39)
  5. GSK Faculty (36)
  6. Surgery (25)

More Groups

People
  1. Robert Motzer (37)
  2. Howard Scher (30)
  3. Michael Morris (25)
  4. David Solit (15)
  5. Dean Bajorin (15)
  6. Susan Slovin (12)

More People

Years
  1. 2024 (4)
  2. 2023 (6)
  3. 2022 (7)
  4. 2021 (10)
  5. 2020 (4)
  6. 2019 (9)

More Years

Publications
  1. Investigational New Drugs (40)
  2. Cancer Chemotherapy and Pharmacology (17)
  3. European Journal of Nuclear Medicine and Molecular Imaging (11)
  4. Annals of Surgical Oncology (10)
  5. Current Oncology Reports (6)
  6. Journal of Neuro-Oncology (5)

More Publications

Results (145)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Good-risk-advanced germ cell tumors: Historical perspective and current standards of care
    Journal Article

    Feldman, D. R.; Motzer, R. J.
    World Journal of Urology (2009)

    Fulltext@MSK | Save
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • Scientific rationale and clinical development of sunitinib malate
    Meeting Abstract

    Ueda, E.; Casali, P. G.; Demetri, G. D.; Hudes, G. R.; Kulke, M. H.; Miller, K. D.; Motzer, R. J.; Baum, C. M.
    Clinical and Experimental Metastasis (2007)

    Fulltext@MSK | Save
  • Tanespimycin (an Hsp90 inhibitor) and trastuzumab is an active combination in patients (pts) with Her2-positive trastuzumab-refractory metastatic breast cancer (MBC): Phase 2 trial
    Meeting Abstract

    Modi, S.; Stopeck, A.; Kinden, H.; Sugarman, S.; Ma, W.; Solit, D.; Kersey, K.; Johnson, R.; Hannah, A. L.; Hudis, C.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Solit, D. B.; Su, Y. B.; Rosen, N.; Sirotnak, F. M.; Smith, R. P.; Azzoli, C. G.; Gomez, J. E.; Miller, V. A.; Kris, M. G.; more...
    Cancer Chemotherapy and Pharmacology (2007)

    Fulltext@MSK | Save
  • A polyvalent vaccine for high-risk prostate patients: "Are more antigens better?"
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Fernandez, C.; Diani, M.; Jefferson, M. P.; Wilton, A.; Kelly, W. K.; Morris, M.; Solit, D.; Clausen, H.; more...
    Cancer Immunology, Immunotherapy (2007)

    Fulltext@MSK | Save
  • 11C-acetate PET imaging in prostate cancer
    Journal Article

    Morris, M. J.; Scher, H. I.
    European Journal of Nuclear Medicine and Molecular Imaging (2007)

    Fulltext@MSK | Save
  • Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma
    Journal Article

    Galsky, M. D.; Mironov, S.; Iasonos, A.; Scattergood, J.; Boyle, M. G.; Bajorin, D. F.
    Investigational New Drugs (2007)

    Fulltext@MSK | Save
  • Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Cestaro, J.; Obbens, E.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2007)

    Fulltext@MSK | Save
  • Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
    Meeting Abstract

    Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save